MICHAEL STANCLIFF: Open Payments
NPI 1417287871 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$270 in 8 payments from 4 companies in 2025. Trend: 2023 $36 · 2024 $161 · 2025 $270
Food & beverage: $270
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 1 | $122 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $65 |
| Pacira Pharmaceuticals Incorporated | 2 | $50 |
| Bioventus LLC | 2 | $33 |
Products named: GVOKE HYPOPEN, JOURNAVX, Zilretta, Iovera, EXOGEN ULTRASOUND BONE HEALING SYSTEM, DUROLANE.
Industry payments across OK — which companies pay providers there.
